Kash SF et al., Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase, Proc Natl Acad Sci USA 94, 1406014065 (1997)
Lewis DA et al., Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia, Biol Psychiatry 46, 616626 (1999)
Marras SA et al., Multiplex detection of single-nucleotide variations using molecular beacons, Genet Anal 14, 151156 (1999)
Rajkowska G and Goldman-Rakic PS, Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria, Cereb Cortex 5, 307322 (1995)
Strange PG, Brain Biochemistry and Brain Disorders, Oxford University Press, Oxford (1992)
Tyagi S and Kramer FR, Molecular beacons: probes that fluoresce upon hybridization, Nat Biotechnol 14, 303308 (1996)
User Manual #2, Relative quantitation of gene expression, product number 4303859, Applied Biosystems
Molecular beacons and their use are licensed under patents and patent applications owned by The Public Health Research Institute of the City of New York, Inc.
* The polymerase chain reaction (PCR) process is covered by patents owned by Hoffman-LaRoche. Use of the PCR process requires a license. The iCycler iQ system includes a licensed thermal cycler and may be used with PCR licenses available from Applera. Its use with authorized reagents also provides a limited PCR license in accordance with the label rights accompanying such reagents. Some applications may require licenses from other parties.
back to top